1. Initial Presentation
Chart Entry:
06/29/2025 21:55 – HR: 256 bpm, BP: 110/92, O₂ Sat: 100% RA.
Response:
This is unstable supraventricular tachycardia (SVT). PALS guidelines require immediate synchronized cardioversion. No cardioversion was attempted.

2. Sedation Before Definitive Treatment
Chart Entry:
21:59 – Ativan 1 mg IM; 22:05 – Ativan 1 mg IVP.
Response:
Two doses of lorazepam were administered before any rhythm control. Sedation is not part of the recommended initial management of unstable SVT. This delayed appropriate intervention.

3. Adenosine Administration
Chart Entry:
22:06–22:10 – Adenosine 6 mg, 12 mg, 12 mg IVP. No change in HR.
Response:
Adenosine is indicated for stable SVT. In unstable SVT with hypotension, cardioversion is required. Continued adenosine despite instability deviates from protocol.

4. Decision to Intubate
Chart Entry:
22:21 – Etomidate 20 mg IVP; 22:22 – Succinylcholine 100 mg IVP. Intubation performed. Rhythm deteriorated to V‑fib during procedure.
Response:
Intubation before cardioversion is not supported by PALS/ACLS standards. This delayed definitive treatment and directly preceded cardiac arrest.

5. Code Medications
Chart Entry:
22:37–22:52 – Epinephrine ×2, Atropine ×3, Lidocaine, Verapamil, Magnesium.
Response:
These were administered reactively during cardiac arrest. The absence of documented cardioversion attempts is a critical omission.

6. Return of Spontaneous Circulation (ROSC)
Chart Entry:
23:26 – Provider note: “ROSC achieved; patient placed on versed, rocuronium, magnesium, lidocaine.”
Response:
Confirms cardiac arrest occurred. However, subsequent documentation minimizes this event.

7. Laboratory Results
•     BNP 262 (H): Cardiac strain. Not addressed in provider note.
•     Troponin I 0.04 (H): Myocardial injury. Not integrated into assessment.
•     CMP: Glucose 151 (H), Creatinine 1.32 (H), CO₂ 20 (L). Indicates metabolic stress and acidosis. Not addressed.
•     Lactate 7.5 (HH): Critical elevation, consistent with shock. Contradicts later description of “stable.”
•     CBC: Mild anemia, thrombocytopenia. Not mentioned.
•     TSH 6.69 (H): Abnormal, not acknowledged.
•     Magnesium 2.3: Normal.
•     D‑Dimer 302: Normal.
•     COVID PCR: Negative.
Response:
Multiple abnormal labs confirmed instability and metabolic crisis. None were integrated into the provider’s narrative.

8. Imaging
Chart Entry:
CXR: ET tube 3 cm above carina; NG tube malpositioned; vascular congestion noted.
Response:
Malpositioned NG tube was documented but not corrected. Vascular congestion was noted but not addressed. Incomplete follow‑through.

9. Transfer Summary
Chart Entry:
01:04 – Transfer accepted; patient described as “fair and stable.”
Response:
This is irreconcilable with the documented cardiac arrest, critical lactate of 7.5, and ongoing ventilator/infusion support. The transfer summary misrepresents the patient’s condition.